Acacia Research Corporation
Medical technology company reports financial performance
Published in Pharma Law Weekly, May 24th, 2005
Acacia Research Corporation comprises two operating groups, the Acacia Technologies group and the CombiMatrix group.
"Acacia Technologies group revenues for the first quarter of 2005 were $1,863,000, consisting of licensing revenues from our Digital Media Transmission (DMT), credit card fraud protection, digital video production, and interactive television technologies. We also received payments of $527,000 from licensees that we recorded as deferred revenues," commented Paul Ryan, Acacia Research Corporation chairman & CEO.
"Since the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2005-05-24)
More Articles from Pharma Law Weekly
- Business Update
Blue Cross and Blue Shield of Florida to become provider of Medicare drug plans - Centers for Medicare & Medicaid Services
CMS proposes FY 2006 rate increases for inpatient stays in acute care hospitals - Centers for Medicare & Medicaid Services
Medicare expands ultrasound treatment for fractures - CepTor Corporation
New compound patents pending for Myodur in muscular dystrophy - Charles University
Stereoselectivity of sibutramine in hepatocytes reported - Corporate Research Group Inc.
Health Net Pharmaceuticals president to be speaker at Medicare Drug Forum - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
